🩹
Healthcare & Biotech Regulatory Redlines & Legal Risk 2018 - 2020

植入物安全风险与诉讼 (Allergan):一种被用了几十年的植入物,为什么会在某一年被要求全球下架?

医疗植入物的风险要靠长期随访数据发现,而不是上市时的注册研究

植入物安全风险与诉讼 (Allergan):巅峰期跨国制药与医疗器械企业,其乳腺植入产品在全球医美市场占有率较高,产品通过整形外科与医美机构植入大量患者体内;终局是产品与罕见淋巴瘤风险的关联被监管确认后全球停售并召回,公司面临大量诉讼与赔付,产品线被下架,公司随后被大型药企收购。

Official site
See the patterns

About this link:网站拒绝自动访问(HTTP 403),链接可能仍然有效,但无法自动确认。

公开报道整理 待核查 Figures as of 2020 2 sources(1 primary) What do these mean?

How to read this bar

This bar states plainly what we know and what we have checked, so you can judge it yourself.

· Review status: “pending” means no editor has checked it against the sources yet; “checked” means key facts match the sources.

· Figures as of: the year the numbers are current to; later changes are out of scope.

· Sources: listed one by one at the bottom of the page. “Primary” means official filings, annual reports or regulator documents.

· Corrections: every change and its basis is published — nothing is edited silently.

Editorial policy → Editorial policy: the full inclusion rules, verification process, AI disclosure and correction promise.

No English translation for this case yet — showing the stored original.
Peak valuation

跨国制药与医疗器械企业,其乳腺植入产品在全球医美市场占有率较高,产品通过整形外科与医美机构植入大量患者体内

Final cost

产品与罕见淋巴瘤风险的关联被监管确认后全球停售并召回,公司面临大量诉讼与赔付,产品线被下架,公司随后被大型药企收购

Attribution votes

2,602 votes cast

Community output

1 plans · 1 insights

Sponsored
把你亲历的失败写进来

投稿会先进入待审,通过后才进入公开目录和站点地图。

Root Causes Consensus Poll

Vote for the primary fatal error that caused this enterprise to collapse.

产品技术

产品设计与罕见风险关联

表面纹理设计与特定淋巴瘤风险相关,注册研究难以充分暴露

856 votes (33%)
外部合规

长期随访与病例登记不足

风险依赖多年使用后累积的病例发现,主动监测不够

719 votes (28%)
组织管理

风险沟通滞后于临床关注

在医学界报告增多后仍未充分调整沟通与使用建议

582 votes (22%)
资本财务

召回与诉讼成本巨大

全球停售、召回与数千起诉讼赔付构成重大损失

445 votes (17%)

Sources

2 sources · 1 primary

These are the references used to compile this case; the numbers match the [1][2] marks in the timeline. Primary sources come first, and archive links are kept where possible.

1 of these are overseas sites (Wikipedia, the Internet Archive, etc.) that may be unreachable from mainland China, so domestic sources (Baidu Baike, mainstream financial media, exchange filings) have been added wherever possible.

  1. [1]
    官方网站(Wikidata 登记) Primary 官方资料
    allergan.com Accessed 2026-10-04
  2. [2]
    维基百科:Allergan 其他 Overseas site
    Wikipedia Accessed 2026-10-04